Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
Laurie Ma(Ottawa Hospital), Jim Dimitroulakos(Ottawa Hospital Research Institute)
Cited by 48
Related Papers
Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
|PLoS ONE|2010|32
Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer
|Translational Oncology|2018|31
Lovastatin‐induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal
|International Journal of Cancer|2013|25